Christopher S. Fields
FDA investigator
Appears on 2 documents from 2018 to 2022, mostly at sites in New York. Most often cites what must you do to determine whether specifications are met? (21 CFR 111.75(c)).
- 2
- Documents on file
- 2.5
- Observations per 483
- 2018
- First seen
- 2022
- Most recent
What they cite most
From 5 observations- 21 CFR 111.75(c)What must you do to determine whether specifications are met?1
- 21 CFR 211.122(a)Materials examination and usage criteria1
- 21 CFR 211.42(c)Design and construction features1
- 21 CFR 211.58Maintenance1
- 21 CFR 211.80(a)General requirements1
Activity by year
2018: 1, 2022: 1
Where
New York 2
Often inspects with
Is Christopher S. Fields coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-07-26 | 483 Gemini Pharmaceuticals, Inc. dba Plus PharmaJul 26, 2022 · Commack, New York | Commack, New York | 1 | |
| 2018-02-16 | 483 Gemini Pharmaceuticals, Inc. dba Plus PharmaFeb 16, 2018 · Commack, New York | Commack, New York | 4 |
About this profile
What does Christopher S. Fields inspect?
Christopher S. Fields appears on 2 documents on file covering 1 site, mostly in New York.
What do they cite most often?
21 CFR 111.75(c) (what must you do to determine whether specifications are met?), followed by 21 CFR 211.122(a) and 21 CFR 211.42(c).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Christopher S. Fields is dated Jul 26, 2022.